|
|
||||
|
NIH's conflicting interests
The Scientist 2004, 18(24):13
|
||||
|
|
||||
|
A year after The Los Angeles Times reported that several high-level scientists and officials at the National Institutes of Health had collectively received more than $2.5 million in consulting fees and stock options from drug and biotech companies, the NIH, Congress, and scientists are still at odds over the agency's conflict-of-interest rules.
|
|
|||||||||
|
|||||||||
|